An AI model developed to predict coronary artery calcium positivity outperformed traditional risk scores among middle-aged ...

New US visa directive allows officers to deny entry based on chronic health conditions like obesity and heart disease.

Tear microRNAs can differ significantly between active and inactive thyroid eye disease, according to research presented at AAO 2025.

The neuroprotective effects of GLP-1RAs were most pronounced among patients with lower baseline cognition in type 2 diabetes.

Paltusotine vs placebo is associated with normalized insulin-like growth factor-1 (IGF-I), stable pituitary tumor size, significant symptom improvement, and sustained IGF-I reduction among adults with ...

The Food and Drug Administration has approved the first generic version of Premarin (conjugated estrogens) tablets.

A cross-ancestry analysis has identified 13 genes associated with a threefold increase in severe obesity risk.

Infrequent dosing of zoledronate was associated with lower fracture risk across 10 years, especially between years 5 and 10.

Despite updates in MELD3.0 to include sex and albumin, women and smaller-bodied patients continue to receive lower transplant priority compared with men of similar disease severity.

The FDA is requesting labeling changes that would remove boxed warnings from all HRT products used to treat menopausal ...

Tirzepatide therapy was associated with neutral effects on heart failure outcomes among patients with type 2 diabetes and/or obesity.

Intensive blood pressure lowering yielded significant net benefits among patients with chronic kidney disease.